An NKG2DL-targeted CAR-NK is ongoing for solid tumors (NCT03415000) based on the phenomenon that several stress molecules in tumor cells recognized by NKG2D are commonly upregulated in solid metastatic tumors [30, 51, 156]. Here, KLRK1 is linked to neoplasm.